Manufacturer Of Medical Equipment | Supplier | Mindray India

Manufacturer Of Medical Equipment | Supplier | Mindray India

Manufacturer Of Medical Equipment | Supplier | Mindray India

Manufacturer Of Medical Equipment | Supplier | Mindray India

Manufacturer Of Medical Equipment | Supplier | Mindray India
Manufacturer Of Medical Equipment | Supplier | Mindray India
Home News Article Latest Innovations in Immunoassay Testing
Latest Innovations in Immunoassay Testing

Mindray 10 Jan 2020

 

Latest Innovations in Immunoassay Testing

Dharampal Sharma

Product Manager - Immunoassay Mindray Medical India Private Limited

The global immunoassay analyzer market is majorly driven by an increasing prevalence of different infectious, immunological or metabolic diseases, increasing demand of ad-vanced diagnostic devices and recent trends of automation and integration which to-gether have led to the introduction of innovative products in this market.

The global immunoassay analyzers market is growing at a healthy CAGR of 15.6% during the forecast period of 2020-2023.

Chemiluminescent immunoassay (CLIA) technology permits analytical procedures with lower analyte detection limits than other immunoassay methods. In other words, CLIA is able to determine the presence of antibodies at extremely low concentrations. Mindray is having Wide range of CLIA Analyzers.

Mindray has recently launched CL-900i one of the world’s smallest, fully automated Chemi-luminescence immunoassay analyzers and integrates a large capacity and fast assay speed into a compact model. It achieves a perfect balance between size and immunoassay testing performance. With enhanced enzymatic Chemiluminescence, patented technology and Min-dray quality heritage, the system guarantees the robust consistence with the higher end an-alyzer.

CL-900i is a simple-to-use Chemiluminescence analyzer with a throughput of 180 tests per hour. Though in a small benchtop package, it has a large onboard capacity of 15 reagents and 50 samples, and supports non-stop refill of samples, reagents and consumables during testing. By integrating the reliable CLIA technology with latest electrical and software improvement, CL-900i enables easy operation and brings confident diagnosis faster than ever.

"The system combines continuous-access, random-access, and STAT processing with a broad testing menu, allowing medium- and Low-volume clinical laboratories to process a variety of immunodiagnostic tests."

CL-900i is designed for both quantitative and qualitative in vitro assay determinations for a broad range of applications; the test menu includes Tumour markers, Cardiac markers, Fertility panel, Diabetes Panel, Anaemia panel, Bone Metabolism parameters and thy-roid markers.

Other unique Features of the system includes, Precise 3 phase magnetic separation with consistent performance, environmental friendly solid-liquid waste separation, continuous loading of samples, reagents and consumables with Intelligent Inventory Management, Non-touch vortexer mixing, Enhanced washing for sensitive assays, Auto dilution facility & flexible positions for STAT & priority.

With Intelligent Sample workflow & High system reliability CL-900i/CL-960i is a robust & compact Immunoassay Analyzers which highly suits for Medium & low volume clinical laboratories

 

 

Related Video: